A Nevada bill headed to the desk of Governor Brian Sandoval (R) would do nothing to decrease prescription drug costs, according to the Council of Citizens Against Government Waste (CCAGW).
Read More »
Accorda Therapeutics receives Refusal to File letter for Inbrija
Research shows benefits of adhering to diabetes medication
Genentech's Actemra receives approval from FDA to treat CRS patients
BIO praises president's signature of FDA Reauthorization Act
ASPEN and Baxter collaborate on 'Smart PN' education